News Headlines Article

F.D.A. Approves Drug for Lupus, an Innovation After 50 Years
New York Times

The first new drug to treat lupus in more than half a century won approval from the Food and Drug Administration on Wednesday, offering a new option for people with lupus, an often-debilitating immune system disease.

The drug, Benlysta, is also the first product approved for its developer, Human Genome Sciences, which has accumulated losses of more than $2 billion since its founding in 1992. GlaxoSmithKline will help market the drug.